摘要
目的:评价氟西汀与帕罗西汀治疗抑郁症的成本-效果。方法:采用循证医学方法收集氟西汀与帕罗西汀治疗抑郁症的临床资料,应用药物经济学的成本-效果分析法进行分析。结果:氟西汀与帕罗西汀治疗抑郁症的治愈率分别为36.30%、58.73%;成本-效果比分别为14.13、9.73;后者相对于前者的增量成本-效果比为2.60。结论:帕罗西汀治疗抑郁症的成本-效果优于氟西汀。
OBJECTIVE: To evaluate the cost - effectiveness of fluxetine and paroxetine in the treatment of depressive disorders. METHODS: The clinical data of fluxetine and paroxetine in the treatment of depressive disorders were collected by evidence - based medicine method and which were evaluated by cost - effectiveness analysis in pharmacoeconomics. RESULTS: The cure rates of fluxetine and paroxetine in the treatment of depressive disorders were 36.30% and 58.73%, respectively, and the cost- effectiveness ratios of which were 14.13 and 9.73, respectively. The incremental cost- effectiveness ratio of the latter vs. the former was 2.60. CONCLUSION: The cost - effectiveness of paroxetine is superior to fluxetine in the treatment of deoressive disorders.
出处
《中国药房》
CAS
CSCD
北大核心
2005年第17期1309-1310,共2页
China Pharmacy
关键词
循证医学
氟西汀
帕罗西汀
抑郁症
成本-效果分析
Evidence - based medicine
Fluoxetine
Paroxetine
Depressive disorder
Cost - effectiveness analysis